Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 921430, 14 pages
http://dx.doi.org/10.1155/2012/921430
Research Article

Synergistic Apoptosis-Inducing Antileukemic Effects of Arsenic Trioxide and Mucuna macrocarpa Stem Extract in Human Leukemic Cells via a Reactive Oxygen Species-Dependent Mechanism

1Graduate Institute of Chinese Pharmaceutical Sciences, China Medical University, Taichung 404, Taiwan
2Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan
3Center of General Education, National Taipei University of Nursing and Health Sciences, Taipei 112, Taiwan
4Department of Health and Nutrition Biotechnology, Asia University, Taichung 413, Taiwan
5Department of Nursing, Hungkuang University, Taichung 433, Taiwan
6Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei 112, Taiwan
7Department and Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei 112, Taiwan

Received 21 January 2011; Revised 10 April 2011; Accepted 17 May 2011

Academic Editor: Alfredo Vannacci

Copyright © 2012 Kuan-Hung Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Zhu, Z. Chen, V. Lallemand-Breitenbach, and H. De Thé, “How acute promyclocytic leukaemia revived arsenic,” Nature Reviews Cancer, vol. 2, no. 9, pp. 705–713, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. Z. Y. Wang and Z. Chen, “Acute promyelocytic leukemia: from highly fatal to highly curable,” Blood, vol. 111, no. 5, pp. 2505–2515, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. S. Tallman, “What is the role of arsenic in newly diagnosed APL?” Best Practice and Research, vol. 21, no. 4, pp. 659–666, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. S. Tallman and J. K. Altman, “Curative strategies in acute promyelocytic leukemia,” Hematology, pp. 391–399, 2008. View at Google Scholar · View at Scopus
  5. W. H. Miller Jr., H. M. Schipper, J. S. Lee, J. Singer, and S. Waxman, “Mechanisms of action of arsenic trioxide,” Cancer Research, vol. 62, no. 14, pp. 3893–3903, 2002. View at Google Scholar · View at Scopus
  6. D. Carney, “Arsenic trioxide mechanisms of action—looking beyond acute promyelocytic leukemia,” Leukemia and Lymphoma, vol. 49, no. 10, pp. 1846–1851, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Verstovsek, F. Giles, A. Quintás-Cardama et al., “Arsenic derivatives in hematologic malignancies: a role beyond acute promyelocytic leukemia?” Hematological Oncology, vol. 24, no. 4, pp. 181–188, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Fox, B. I. Razzouk, B. C. Widemann et al., “Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma,” Blood, vol. 111, no. 2, pp. 566–573, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. R. Litzow, S. Lee, J. M. Bennett et al., “A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia,” Haematologica, vol. 91, no. 8, pp. 1105–1108, 2006. View at Google Scholar · View at Scopus
  10. Editorial Board of Zhong Hua Ben Cao, State Administration of Traditional Chinese Medicine, Zhong Hua Ben Cao (China Herbal), vol. 4, Shanghai Scientific Technology Press, Shanghai, China, 1999.
  11. K. H. Lu, Y. F. Chang, P. H. Yin et al., “In vitro and in vivo apoptosis-inducing antileukemic effects of Mucuna macrocarpa stem extract on HL-60 human leukemia cells,” Integrative Cancer Therapies, vol. 9, no. 3, pp. 298–308, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Pelicano, L. Feng, Y. Zhou et al., “Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism,” Journal of Biological Chemistry, vol. 278, no. 39, pp. 37832–37839, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. N. A. Doudican, B. Bowling, and S. J. Orlow, “Enhancement of arsenic trioxide cytotoxicity by dietary isothiocyanates in human leukemic cells via a reactive oxygen species-dependent mechanism,” Leukemia Research, vol. 34, no. 2, pp. 229–234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. A. M. Ramos and P. Aller, “Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines,” Biochemical Pharmacology, vol. 75, no. 10, pp. 1912–1923, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Sánchez, D. Amrán, C. Fernández, E. De Blas, and P. Aller, “Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK),” International Journal of Cancer, vol. 123, no. 5, pp. 1205–1214, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. H.-J. Lee, Y. Su, P.-H. Yin, H.-C. Lee, and C.-W. Chi, “PPARγ/PGC-1α pathway in E-cadherin expression and motility of HepG2 cells,” Anticancer Research, vol. 29, no. 12, pp. 5057–5063, 2009, Erratum: vol. 30, no. 3, pp. 1033, 2010. View at Google Scholar
  17. T. C. Chou, “Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies,” Pharmacological Reviews, vol. 58, no. 3, pp. 621–681, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. T. C. Chou, “Drug combination studies and their synergy quantification using the Chou-Talalay method,” Cancer Research, vol. 70, no. 2, pp. 440–446, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Fernández, A. M. Ramos, P. Sancho, D. Amrán, E. De Blas, and P. Aller, “12-O-tetradecanoylphorbol-13-acetate may both potentiate and decrease the generation of apoptosis by the antileukemic agent arsenic trioxide in human promonocytic cells: regulation by extracellular signal-regulated protein kinases and glutathione,” Journal of Biological Chemistry, vol. 279, no. 5, pp. 3877–3884, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. S. J. Ralph, “Arsenic-based antineoplastic drugs and their mechanisms of action,” Metal-Based Drugs, vol. 2008, Article ID 260146, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. T.-Y. Lai, C.-J. Yao, C.-M. Yang et al., “Targeting PML-RARα and oncogenic signaling pathways by Chinese herbal mixture Tien-Hsien liquid in acute promyelocytic leukemia NB4 cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 984154, 11 pages, 2011. View at Publisher · View at Google Scholar
  22. H. Pelicano, J. S. Carew, T. J. McQueen et al., “Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C,” Leukemia, vol. 20, no. 4, pp. 610–619, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Y. Peng, J. Jiang, H. T. Zheng, and X. S. Liu, “Growth-inhibiting effects of arsenic trioxide plus epigenetic therapeutic agents on leukemia cell lines,” Leukemia and Lymphoma, vol. 51, no. 2, pp. 297–303, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. B. D'Autréaux and M. B. Toledano, “ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis,” Nature Reviews Molecular Cell Biology, vol. 8, no. 10, pp. 813–824, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. F. Chang, Y. C. Hsu, H. F. Hung et al., “Quercetin induces oxidative stress and potentiates the apoptotic action of 2-methoxyestradiol in human hepatoma cells,” Nutrition and Cancer, vol. 61, no. 5, pp. 735–745, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Wang, L. Li, H. Cang, G. Shi, and J. Yi, “NADPH oxidase-derived reactive oxygen species are responsible for the high susceptibility to arsenic cytotoxicity in acute promyelocytic leukemia cells,” Leukemia Research, vol. 32, no. 3, pp. 429–436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Pelicano, L. Feng, Y. Zhou et al., “Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism,” Journal of Biological Chemistry, vol. 278, no. 39, pp. 37832–37839, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Lu, E. H. Chew, and A. Holmgren, “Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 30, pp. 12288–12293, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Jing, J. Dai, R. M. E. Chalmers-Redman, W. G. Tatton, and S. Waxman, “Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway,” Blood, vol. 94, no. 6, pp. 2102–2111, 1999. View at Google Scholar · View at Scopus
  30. Y. Sánchez, G. P. Simón, E. Calviño, E. De Blas, and P. Aller, “Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines,” Journal of Pharmacology and Experimental Therapeutics, vol. 335, no. 1, pp. 114–123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. T. Wu, S. B. Wu, W. Y. Lee, and Y. H. Wei, “Mitochondrial respiratory dysfunction-elicited oxidative stress and posttranslational protein modification in mitochondrial diseases,” Annals of the New York Academy of Sciences, vol. 1201, pp. 147–156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Pervaiz and M. V. Clément, “A permissive apoptotic environment: function of a decrease in intracellular superoxide anion and cytosolic acidification,” Biochemical and Biophysical Research Communications, vol. 290, no. 4, pp. 1145–1150, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Trachootham, W. Lu, M. A. Ogasawara, N. R. D. Valle, and P. Huang, “Redox regulation of cell survival,” Antioxidants and Redox Signaling, vol. 10, no. 8, pp. 1343–1374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Huang, L. Feng, E. A. Oldham, M. J. Keating, and W. Plunkett, “Superoxide dismutase as a target for the selective killing of cancer cells,” Nature, vol. 407, no. 6802, pp. 390–395, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Franco and J. A. Cidlowski, “Apoptosis and glutathione: beyond an antioxidant,” Cell Death and Differentiation, vol. 16, no. 10, pp. 1303–1314, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Matsuda, K. Yoshida, K. Miyagawa et al., “Rotenoids and flavonoids with anti-invasion of HT1080, anti-proliferation of U937, and differentiation-inducing activity in HL-60 from Erycibe expansa,” Bioorganic and Medicinal Chemistry, vol. 15, no. 3, pp. 1539–1546, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Konoshima, M. Kokumai, M. Kozuka, H. Tokuda, H. Nishino, and A. Iwashima, “Anti-tumor-promoting activities of afromosin and soyasaponin I isolated from Wistaria brachybotrys,” Journal of Natural Products, vol. 55, no. 12, pp. 1776–1778, 1992. View at Google Scholar · View at Scopus
  38. N. J. M. Raynal, L. Momparler, M. Charbonneau, and R. L. Momparler, “Antileukemic activity of genistein, a major isoflavone present in soy products,” Journal of Natural Products, vol. 71, no. 1, pp. 3–7, 2008. View at Publisher · View at Google Scholar · View at Scopus